← Back to all trials
Enrolling By Invitation
NCT05708677
A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB
Conditions: RDEB
Sex: All
Ages: 6 Years – N/A
Healthy volunteers: No
Enrollment: 22
Sponsor: Abeona Therapeutics, Inc
Location: Stanford University Redwood City California
Summary
A Long-Term Extension Study for Participants Previously Treated with EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Eligibility Criteria
Inclusion Criteria:
* Willing and able to give consent/assent;
* If under the age of 18, guardian(s) is/are willing and able to give consent;
* Prior study treatment with EB-101.
Exclusion Criteria:
* Inability to properly follow protocol as determined by the Principal Investigator
Source: ClinicalTrials.gov (NCT05708677). StuddyBuddy aggregates publicly available trial information.
